The discovery of the cancer enzyme
This wonderful film features Professor Gera Neufeld of Israel’s Technion whose team discovered the LOXL2 enzyme and has led to drug treatments for cancer and fibrosis.
You’ve got to hand it to Israel
The US Food and Drug Administration has approved Israeli biotech Bioness’ H200 Wireless Hand Rehabilitation System for treating hand paralysis brought on by strokes, spinal injury etc.
Parkinson’s treatment trial success
Israel’s InSightec Ltd. today reported success in a clinical trial of its noninvasive focused ultrasound ExAblate Neuro system to treat chronic neurological disorders.
Israel hosts congress for medical clowns
At least 200 medical clowns from America, Europe and Australia will attend the October convention. Dream Doctors, funded by Magi Foundation, helped set up the world's only undergraduate degree program in clown therapy as a paramedical profession at the University of Haifa.
Rebuilding limbs
Father and son, Yehuda and Israel Pilosof, work around the clock making prosthetic limbs for survivors of disasters such as the Haiti earthquake. Their life motto is “make possible what is impossible”.
The balloon goes up
Israel’s BioProtect has developed a biodegradable balloon that creates a physical separation between tumours and healthy tissues during radiation therapy, reducing damage to healthy tissue.
Lymphoma trial succeeds
Israel’s CureTech Ltd. announced the final successful results of its Phase II clinical trial of CT-011 stem cell treatment of Diffuse Large B Cell Lymphoma.
Stem cells can treat radiation sickness
Israeli biotech Pluristem Therapeutics has announced that initial animal studies found that its placental stem cells can treat Acute Radiation Syndrome (ARS).
Hadassah Hospital’s Healing Tower
Construction of the new 14-storey hospital building is complete. It will replace the current 50 year-old round building, which will become Hadassah’s research and admin centre.
Israelis discover short-sightedness gene
Ben Gurion University researchers have identified a mutation of the gene LEPREL1 by studying a Bedouin tribe where the defect is the cause of hereditary myopia.